About Delfa

Billions of people still suffer from every-day diseases.

One key reason? Clinical trials are broken.

Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.

Delfa is fixing this with autonomous AI agents. We're building AI agents to automate clinical trials.

In the last year from we’ve already:

• Deployed onto 500+ trials across multiple conditions

• Reached seven figures in ARR, growing 25% MoM

• Raised an oversubscribed $3.8m seed from tier-one AI investors

What You'll Do

You'll build and scale the core systems that enable Delfa's AI agents to deliver real-world clinical impact.

• Design, build, and scale AI agent systems end-to-end: from voice interactions to intelligent workflow orchestration across trial sites

• Own complex projects from architecture to deployment, with real autonomy over technical decisions